Three doses of RTS,S/AS01, a candidate malaria vaccine, previously showed 28% efficacy against clinical malaria during 48 months of follow-up (NEJM JW
One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage PlusPublished in last 50 years